Inaugural BIOTECanada-UCB Pharma (UCBJF.PK) National Health Innovation Patient Advocacy Awards Granted
9/25/2008 9:39:29 AM
More...
|
Entelos, Inc. Enters Research Deal with UCB Pharma (UCBJF.PK) in Rheumatoid Arthritis
1/21/2008 8:05:36 AM
More...
|
Mylan Laboratories Inc. (MYL) Settles Its First-to-File Opportunity on Levetiracetam with UCB Pharma (UCBJF.PK)
10/5/2007 9:46:18 AM
More...
|
UCB Group (UCBJF.PK) And Sanofi-Aventis (France) (SASY.PA) Sign A Co-Promotion Agreement For Xyzal(R); In The United States
9/25/2006 4:44:18 PM
More...
|
Crucell N.V. (CRXL) And UCB Group (UCBJF.PK) Sign STAR(TM) License Agreement
9/7/2006 4:15:58 PM
More...
|
Solvay SA Considering Buying UCB Bioproducts (UCBJF.PK)
11/22/2005 6:05:48 PM
More...
|
UCB Pharma (UCBJF.PK) Release: Study To Measure Impact Of Epilepsy And Epilepsy Medication On Cognitive Ability In Children
11/8/2005 1:03:44 PM
More...
|
UCB Presents Positive Cimzia(TM) Results From Pivotal Phase III Crohn's Disease Trial At Major U.S. Medical Meeting
10/31/2005 10:24:41 AM
More...
|
UCB Pharma (UCBJF.PK) Release: Regulatory Filing Submitted To FDA For Keppra(R) (Levetiracetam) As Treatment For Myoclonic Seizures
10/27/2005 11:27:51 AM
More...
|
Orphan Medical, Inc. (ORPH) Release: FDA Accepts Xyrem sNDA For Review, User Fee Deadline Set For November 18, 2005, Company Receives $1 Million Payment From UCB Pharma (UCBJF.PK)
10/19/2005 5:13:05 PM
More...
|
|